Neos Therapeutics, Inc. is a pharmaceutical company focused on developing, manufacturing and commercializing products utilizing its proprietary modified-release drug delivery technology platforms. Neos, which is initially focusing on the treatment of ADHD, has two other branded product candidates that are XR medications in ODT or oral suspension dosage forms. Contact: HR@NeosTX.com
View Top Employees from Neos Therapeutics, Inc.Website | http://www.neostx.com/ |
Ticker | NEOS |
Revenue | $64 million |
Funding | $342.4 million |
Employees | 46 (46 on RocketReach) |
Founded | 2008 |
Address | 2940 N State Highway 360, Grand Prairie, Texas 75050, US |
Phone | (972) 408-1300 |
Fax | (972) 408-1143 |
Technologies |
JavaScript,
HTML,
PHP
+21 more
(view full list)
|
Industry | Pharmaceutical Manufacturing, Pharmaceuticals, Biotechnology, Healthcare, Science and Engineering, Life Science, Medical, Health Care, Therapeutics |
Web Rank | 5 Million |
Keywords | Neos Therapeutics, Carolyn Sikes Neos, Neos Therapeutics Inc, Neo Therapeutics, Neos |
Competitors | Chiesi USA, Inc., Martin's Wellness & Compounding Pharmacies, Orexo AB publ, TWi Pharmaceuticals, Inc., Tris Pharma |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 62 Companies, NAICS Code 62151 Companies, NAICS Code 621 Companies, NAICS Code 6215 Companies, NAICS Code 33 Companies |
Looking for a particular Neos Therapeutics, Inc. employee's phone or email?
The Neos Therapeutics, Inc. annual revenue was $64 million in 2024.
Richard Eisenstadt is the CFO of Neos Therapeutics, Inc..
46 people are employed at Neos Therapeutics, Inc..
Neos Therapeutics, Inc. is based in Grand Prairie, Texas.
The NAICS codes for Neos Therapeutics, Inc. are [62, 62151, 621, 6215, 33].
The SIC codes for Neos Therapeutics, Inc. are [28, 283].